December 6th, 2022 | 🕒
iSpeech BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its
April 4th, 2022 | 🕒
Powered by iSpeech Company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret
February 8th, 2022 | 🕒
Convert Text to Speech BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing
January 27th, 2022 | 🕒
iSpeech.org BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of
August 6th, 2021 | 🕒
Convert Text to Speech BILLERICA, Mass.--(BUSINESS WIRE)--Aug 6, 2021-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the
August 6th, 2021 | 🕒
iSpeech.org BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of
June 7th, 2021 | 🕒
iSpeech BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of
March 17th, 2021 | 🕒
iSpeech BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced
March 17th, 2021 | 🕒
TTS BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced
Gloss